BAJAJ BROKING

Notification close image
No new Notification messages
card image
Vikram Solar IPO is Open!
Apply for the Vikram Solar IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Anondita Medicare IPO: Things Smart Investors Need to Know

Anondita Medicare Limited, established in March 2024, operates in the healthcare and wellness sector with a focus on manufacturing flavoured male condoms under its flagship brand “COBRA.” The company runs a production facility in Sector 80, Noida, Uttar Pradesh, with an annual capacity of nearly 562 million condoms, as certified in June 2025. To support sustainable practices, the plant uses CNG as a cleaner fuel option, aligning with environmentally conscious manufacturing processes. As of July 31, 2025, the company had a workforce of 280 employees contributing to its operations and growth.

The company maintains a wide domestic and international presence, supplying to Southeast Asia, Africa, and the Middle East. Its distribution network involves wholesalers, retailers, e-commerce platforms, and strong ties with government health programs, NGOs, and global health organisations. These collaborations enable Anondita Medicare to support family planning initiatives while ensuring accessibility of its products across diverse markets, strengthening its position as it enters the IPO space.

For more details, visit the Anondita Medicare IPO page.

Anondita Medicare IPO Details and Objectives

Details

Information

IPO Date

August 22, 2025 to August 26, 2025

Issue Size

47,93,000 shares

(aggregating up to ₹69.50 Cr)

Price Band

₹137 to ₹145 per share

Lot Size

1000 shares

Listing At

NSE SME

Market Maker

Mansi Share & Stock Broking Pvt.Ltd.

Purpose of the IPO

  • Capital Expenditure

  • Working Capital Requirement

  • Unidentified Acquisition and General Corporate Purposes

Timeline of Anondita Medicare IPO

Event

Date

IPO Open Date

Fri, Aug 22, 2025

IPO Close Date

Tue, Aug 26, 2025

Tentative Allotment

Thu, Aug 28, 2025

Initiation of Refunds

Fri, Aug 29, 2025

Credit of Shares to Demat

Fri, Aug 29, 2025

Tentative Listing Date

Mon, Sep 1, 2025

Cut-off time for UPI mandate confirmation

5 PM on August 26, 2025

Pricing & Lot Size of Anondita Medicare IPO

Price Band for the IPO

  • ₹137 to ₹145 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

2,000

₹2,90,000

Individual investors (Retail) (Max)

2

2,000

₹2,90,000

S-HNI (Min)

3

3,000

₹4,35,000

S-HNI (Max)

6

6,000

₹8,70,000

B-HNI (Min)

7

7,000

₹10,15,000

How to Apply for the Anondita Medicare IPO?

Online Application Process

  • Log in to Your Trading Account: Access your trading account through your broker’s platform.

  • Navigate to the IPO Section: Go to the IPO section to view active IPO listings.

  • Select Anondita Medicare IPO: Find "Anondita Medicare IPO" and click on the ‘Apply’ button.

  • Enter Application Details: Specify the number of lots (minimum lot size: 1000 shares) and the bid price within the range of ₹137 to ₹145 per share.

  • Provide Your UPI ID: Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit: Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on August 26, 2025, to complete your application process.

Additional Read-   How to Apply for the Anondita Medicare IPO?

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹37.80 crore in FY23 to ₹78.27 crore as of March 2025.

  • Total income: Reached ₹77.13 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹16.42 crore for March 2025.

  • Net Worth: Recorded at ₹37.87 crore in FY25.

  • Reserves and Surplus: Recorded at ₹24.58 crore (March 2025), growing steadily over the years.

  • EBITDA: Stood at ₹25.65 crore in March 2025.

Recent Performance and Growth Prospects

  • The company has consistently expanded its asset base over the recent financial years, indicating stability and growth in operations.

  • Its income levels have shown a steady upward movement, reflecting increasing business activity.

  • Profitability has remained positive, highlighting the company’s ability to manage costs effectively and generate returns.

  • The organisation has strengthened its net worth, which points towards a solid financial position.

  • Reserves and surplus have continued to grow, demonstrating healthy retention of earnings for future expansion.

  • Operational performance has improved, with earnings before interest, taxes, depreciation, and amortisation showing a strong upward trend.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company’s business is concentrated in the condom manufacturing segment, making it sensitive to changes in demand, competition, and regulatory guidelines in the healthcare and wellness industry.

  • Expansion into multiple international markets exposes the business to risks such as currency fluctuations, trade regulations, and reliance on global health initiatives.

Opportunities and Growth Potential

  • A wide domestic and international distribution network, along with collaborations with NGOs and government programmes, positions the company to capture growing demand for family planning and wellness products.

  • Focus on sustainable production methods, increasing brand presence, and strong institutional partnerships provide a platform for long-term growth and diversification.

Key Performance Indicator (KPI)

KPI

Values

ROE

41.71%

ROCE

37.42%

Debt/Equity

0.70

RoNW

41.71%

PAT Margin

21.32%

EBITDA Margin

33.32%

Price to Book Value

15.07

Anondita Medicare IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Maashitla Securities Pvt.Ltd. 

Narnolia Financial Services Ltd. 

Company Address of Anondita Medicare Ltd

Anondita Medicare Ltd. Flat No.704 Narmada Block, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, New Delhi, 110070

Phone: 0120-4520300

Email: info@anonditamedicare.com

Website: https://anonditamedicare.com/

Conclusion

Anondita Medicare Limited operates in the healthcare and wellness sector with a focus on male condom manufacturing under its brand “COBRA.” The company has established its production base in Noida, supported by sustainable fuel practices and a workforce contributing to its operations. Its presence spans both domestic and international markets through collaborations with wholesalers, e-commerce platforms, NGOs, and government programmes.

The upcoming IPO has been structured to meet capital expenditure needs, working capital requirements, and other general purposes. Investors can review the objectives, pricing, and application process to understand how the offering aligns with the company’s ongoing business activities and expansion plans.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Anondita Medicare IPO. 

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|